{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T10:31:00Z","timestamp":1781087460201,"version":"3.54.1"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J. of Cardiovasc. Trans. Res."],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1007\/s12265-016-9686-0","type":"journal-article","created":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T13:25:09Z","timestamp":1459517109000},"page":"202-213","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Implantation of a Novel Allogeneic Mesenchymal Precursor Cell Type in Patients with Ischemic Cardiomyopathy Undergoing Coronary Artery Bypass Grafting: an Open Label Phase IIa Trial"],"prefix":"10.1007","volume":"9","author":[{"given":"Kyriakos","family":"Anastasiadis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Polychronis","family":"Antonitsis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Westaby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ajan","family":"Reginald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabena","family":"Sultan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Argirios","family":"Doumas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Efthimiadis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin John","family":"Evans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,4,1]]},"reference":[{"key":"9686_CR1","first-page":"1","volume":"1","author":"E Braunwald","year":"2013","unstructured":"Braunwald, E. (2013). Heart failure. Journal of the American College of Cardiology Heart Failure, 1, 1\u201320.","journal-title":"Journal of the American College of Cardiology Heart Failure"},{"key":"9686_CR2","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.gheart.2013.12.007","volume":"9","author":"AE Moran","year":"2014","unstructured":"Moran, A. E., Tzong, K. Y., Forouzanfar, M. H., et al. (2014). Variations in ischemic heart disease burden by age, country, and income: the global burden of diseases, injuries and risk factors 2010 study. Global Heart, 9, 91\u201399.","journal-title":"Global Heart"},{"key":"9686_CR3","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1161\/CIRCULATIONAHA.106.666818","volume":"115","author":"KA Ammar","year":"2007","unstructured":"Ammar, K. A., Jacobsen, S. J., Mahoney, D. W., et al. (2007). Heart failure prevalence and prognostic significance of heart failure stages. Application of the American College of Cardiology\/American Heart Association heart failure staging criteria in the community. Circulation, 115, 1563\u20131570.","journal-title":"Circulation"},{"issue":"Suppl. A","key":"9686_CR4","doi-asserted-by":"publisher","first-page":"A13","DOI":"10.1253\/circj.CJ-08-0481","volume":"72","author":"T Oka","year":"2008","unstructured":"Oka, T., & Komuro, I. (2008). Molecular mechanisms underlying the transition of cardiac hypertrophy to heart failure. Circulation Journal, 72(Suppl. A), A13\u2013A16.","journal-title":"Circulation Journal"},{"key":"9686_CR5","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1161\/01.CIR.97.3.282","volume":"97","author":"M Gheorghiade","year":"1998","unstructured":"Gheorghiade, M., & Bonow, R. O. (1998). Chronic heart failure in the United States: a manifestation of coronary artery disease. Circulation, 97, 282\u2013289.","journal-title":"Circulation"},{"key":"9686_CR6","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1016\/j.jtcvs.2006.08.077","volume":"133","author":"C Stamm","year":"2007","unstructured":"Stamm, C., Kleine, H. D., Choi, Y. H., et al. (2007). Intramyocardial delivery of CD133+ bone marrow cells and coronary artery bypass grafting for chronic ischemic heart disease: safety and efficacy studies. Journal of Thoracic and Cardiovascular Surgery, 133, 717\u2013725.","journal-title":"Journal of Thoracic and Cardiovascular Surgery"},{"key":"9686_CR7","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1007\/s12265-014-9580-6","volume":"7","author":"T Santoso","year":"2014","unstructured":"Santoso, T., Siu, C. W., Irawan, C., et al. (2014). Endomyocardial implantation of autologous bone marrow mononuclear cells in advanced ischemic heart failure: a randomized placebo-controlled trial (END-HF). Journal of Cardiovascular Translational Research, 7, 545\u2013552.","journal-title":"Journal of Cardiovascular Translational Research"},{"key":"9686_CR8","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1161\/CIRCRESAHA.114.304792","volume":"117","author":"MR Afzal","year":"2015","unstructured":"Afzal, M. R., Samanta, A., Shah, Z. I., et al. (2015). Adult bone marrow cell therapy for ischemic heart disease: evidence and insights from randomized controlled trials. Circulation Research, 117, 558\u2013575.","journal-title":"Circulation Research"},{"key":"9686_CR9","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1001\/jama.2013.282909","volume":"311","author":"AW Heldman","year":"2014","unstructured":"Heldman, A. W., DiFede, D. L., Fishman, J. E., et al. (2014). Transendocardial mesenchymal stem cells and mononuclear bone marrow cells for ischemic cardiomyopathy: the TAC-HFT randomized trial. JAMA, 311, 62\u201373.","journal-title":"JAMA"},{"key":"9686_CR10","volume":"4","author":"SA Fisher","year":"2014","unstructured":"Fisher, S. A., Brunskill, S. J., Doree, C., Mathur, A., Taggart, D. P., & Martin-Rendon, E. (2014). Stem cell therapy for chronic ischaemic heart disease and congestive heart failure. Cochrane Database of Systematic Reviews, 4, CD007888.","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"9686_CR11","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1080\/14653240600855905","volume":"8","author":"M Dominici","year":"2006","unstructured":"Dominici, M., Le Blanc, K., et al. (2006). Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy, 8, 315\u2013317.","journal-title":"Cytotherapy"},{"key":"9686_CR12","doi-asserted-by":"publisher","first-page":"e123","DOI":"10.1016\/j.jacc.2011.08.009","volume":"58","author":"LD Hillis","year":"2011","unstructured":"Hillis, L. D., Smith, P. K., Anderson, J. L., et al. (2011). American College of Cardiology Foundation; American Heart Association Task Force on Practice Guidelines; American Association for Thoracic Surgery; Society of Cardiovascular Anesthesiologists; Society of Thoracic Surgeons. 2011 ACCF\/AHA guideline for coronary artery bypass graft surgery. A report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines. Developed in collaboration with the American Association for Thoracic Surgery, Society of Cardiovascular Anesthesiologists, and Society of Thoracic Surgeons. Journal of the American College of Cardiology, 58, e123\u2013e210.","journal-title":"Journal of the American College of Cardiology"},{"key":"9686_CR13","doi-asserted-by":"publisher","first-page":"2722","DOI":"10.1093\/eurheartj\/ehp265","volume":"30","author":"KH Schuleri","year":"2009","unstructured":"Schuleri, K. H., Feigenbaum, G. S., Centola, M., et al. (2009). Autologous mesenchymal stem cells produce reverse remodelling in chronic ischaemic cardiomyopathy. European Heart Journal, 30, 2722\u20132732.","journal-title":"European Heart Journal"},{"key":"9686_CR14","doi-asserted-by":"publisher","first-page":"17384","DOI":"10.1073\/pnas.1103650108","volume":"108","author":"S Chiesa","year":"2011","unstructured":"Chiesa, S., Morbelli, S., Morando, S., et al. (2011). Mesenchymal stem cells impair in vivo T-cell priming by dendritic cells. Proceedings of the National Academy of Sciences of the United States of America, 108, 17384\u201317389.","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"9686_CR15","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1161\/CIRCRESAHA.112.300730","volume":"113","author":"JH Houtgraaf","year":"2013","unstructured":"Houtgraaf, J. H., de Jong, R., Kazemi, K., et al. (2013). Intracoronary infusion of allogeneic mesenchymal precursor cells directly after experimental acute myocardial infarction reduces infarct size, abrogates adverse remodeling, and improves cardiac function. Circulation Research, 113, 153\u2013166.","journal-title":"Circulation Research"},{"key":"9686_CR16","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1016\/S0301-472X(03)00110-3","volume":"31","author":"K Le Blanc","year":"2003","unstructured":"Le Blanc, K., Tammik, C., Rosendahl, K., et al. (2003). HLA expression and immunologic properties of differentiated and undifferentiated mesenchymal stem cells. Experimental Hematology, 31, 890\u2013896.","journal-title":"Experimental Hematology"},{"key":"9686_CR17","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/s11373-004-8183-7","volume":"12","author":"E Klyushnenkova","year":"2005","unstructured":"Klyushnenkova, E., Mosca, J. D., Zernetkina, V., et al. (2005). T cell responses to allogeneic human mesenchymal stem cells: immunogenicity, tolerance, and suppression. Journal of Biomedical Science, 12, 47\u201357.","journal-title":"Journal of Biomedical Science"},{"key":"9686_CR18","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1001\/jama.2012.418","volume":"307","author":"EC Perin","year":"2012","unstructured":"Perin, E. C., Willerson, J. T., Pepine, C. J., et al. (2012). Effect of transendocardial delivery of autologous bone marrow mononuclear cells on functional capacity, left ventricular function, and perfusion in chronic heart failure: the FOCUS-CCTRN trial. JAMA, 307, 1717\u20131726.","journal-title":"JAMA"},{"key":"9686_CR19","doi-asserted-by":"publisher","first-page":"2369","DOI":"10.1001\/jama.2012.25321","volume":"308","author":"JM Hare","year":"2012","unstructured":"Hare, J. M., Fishman, J. E., Gerstenblith, G., et al. (2012). Comparison of allogeneic vs autologous bone marrow-derived mesenchymal stem cells delivered by transendocardial injection in patients with ischemic cardiomyopathy: the POSEIDON randomized trial. JAMA, 308, 2369\u20132379.","journal-title":"JAMA"},{"key":"9686_CR20","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1089\/wound.2012.0408","volume":"3","author":"JK Fraser","year":"2014","unstructured":"Fraser, J. K., Hicok, K. C., Shanahan, R., et al. (2014). The Celution\u00ae system: automated processing of adipose-derived regenerative cells in a functionally closed system. Advances in Wound Care (New Rochelle), 3, 38\u201345.","journal-title":"Advances in Wound Care (New Rochelle)"},{"key":"9686_CR21","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.yjmcc.2007.11.010","volume":"44","author":"D Zhang","year":"2008","unstructured":"Zhang, D., Fan, G. C., Zhou, X., et al. (2008). Over-expression of CXCR4 on mesenchymal stem cells augments myoangiogenesis in the infarcted myocardium. Journal of Molecular and Cellular Cardiology, 44, 281\u2013292.","journal-title":"Journal of Molecular and Cellular Cardiology"},{"key":"9686_CR22","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0046158","volume":"7","author":"J Liang","year":"2012","unstructured":"Liang, J., Huang, W., Yu, X., et al. (2012). Suicide gene reveals the myocardial neovascularization role of mesenchymal stem cells overexpressing CXCR4 (MSC(CXCR4)). PLoS One, 7, e46158.","journal-title":"PLoS One"},{"key":"9686_CR23","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1089\/scd.2011.0126","volume":"21","author":"W Huang","year":"2012","unstructured":"Huang, W., Wang, T., Zhang, D., et al. (2012). Mesenchymal stem cells overexpressing CXCR4 attenuate remodeling of postmyocardial infarction by releasing matrix metalloproteinase-9. Stem Cells and Development, 21, 778\u2013789.","journal-title":"Stem Cells and Development"},{"key":"9686_CR24","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1161\/CIRCRESAHA.114.303180","volume":"114","author":"V Karantalis","year":"2014","unstructured":"Karantalis, V., DiFede, D. L., Gerstenblith, G., et al. (2014). Autologous mesenchymal stem cells produce concordant improvements in regional function, tissue perfusion, and fibrotic burden when administered to patients undergoing coronary artery bypass grafting: the prospective randomized study of mesenchymal stem cell therapy in patients undergoing cardiac surgery (PROMETHEUS) trial. Circulation Research, 114, 1302\u20131310.","journal-title":"Circulation Research"},{"key":"9686_CR25","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1007\/s12265-010-9253-z","volume":"4","author":"N Dib","year":"2011","unstructured":"Dib, N., Khawaja, H., Varner, S., et al. (2011). Cell therapy for cardiovascular disease: a comparison of methods of delivery. Journal of Cardiovascular Translational Research, 4, 177\u2013181.","journal-title":"Journal of Cardiovascular Translational Research"},{"issue":"Suppl I","key":"9686_CR26","first-page":"I150","volume":"112","author":"D Hou","year":"2005","unstructured":"Hou, D., Youssef, E. A., Brinton, T. J., et al. (2005). Radiolabeled cell distribution after intramyocardial, intracoronary, and interstitial retrograde coronary venous delivery: implications for current clinical trials. Circulation, 112(Suppl I), I150\u2013I156.","journal-title":"Circulation"},{"key":"9686_CR27","doi-asserted-by":"publisher","first-page":"1847","DOI":"10.1016\/S0140-6736(11)61590-0","volume":"378","author":"R Bolli","year":"2011","unstructured":"Bolli, R., Chugh, A. R., D\u2019Amario, D., et al. (2011). Cardiac stem cells in patients with ischaemic cardiomyopathy (SCIPIO): initial results of a randomised phase 1 trial. Lancet, 378, 1847\u20131857.","journal-title":"Lancet"},{"key":"9686_CR28","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1186\/1745-6215-13-99","volume":"13","author":"P Donndorf","year":"2012","unstructured":"Donndorf, P., Kaminski, A., Tiedemann, G., Kundt, G., & Steinhoff, G. (2012). Validating intramyocardial bone marrow stem cell therapy in combination with coronary artery bypass grafting, the PERFECT phase III randomized multicenter trial: study protocol for a randomized controlled trial. Trials, 13, 99.","journal-title":"Trials"},{"key":"9686_CR29","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1007\/s12265-014-9575-3","volume":"7","author":"F Franchi","year":"2014","unstructured":"Franchi, F., Ezenekwe, A., Wellkamp, L., Peterson, K. M., Lerman, A., & Rodriguez-Porcel, M. (2014). Renin inhibition improves the survival of mesenchymal stromal cells in a mouse model of myocardial infarction. Journal of Cardiovascular Translational Research, 7, 560\u2013569.","journal-title":"Journal of Cardiovascular Translational Research"},{"key":"9686_CR30","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1161\/CIRCRESAHA.110.222703","volume":"107","author":"KE Hatzistergos","year":"2010","unstructured":"Hatzistergos, K. E., Quevedo, H., Oskouei, B. N., et al. (2010). Bone marrow mesenchymal stem cells stimulate cardiac stem cell proliferation and differentiation. Circulation Research, 107, 913\u2013922.","journal-title":"Circulation Research"},{"key":"9686_CR31","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1161\/CIRCRESAHA.108.176826","volume":"103","author":"M Gnecchi","year":"2008","unstructured":"Gnecchi, M., Zhang, Z., Ni, A., & Dzau, V. J. (2008). Paracrine mechanisms in adult stem cell signaling and therapy. Circulation Research, 103, 1204\u20131219.","journal-title":"Circulation Research"},{"key":"9686_CR32","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1161\/01.RES.0000118601.37875.AC","volume":"94","author":"T Kinnaird","year":"2004","unstructured":"Kinnaird, T., Stabile, E., Burnett, M. S., et al. (2004). Marrow-derived stromal cells express genes encoding a broad spectrum of arteriogenic cytokines and promote in vitro and in vivo arteriogenesis through paracrine mechanisms. Circulation Research, 94, 678\u2013685.","journal-title":"Circulation Research"},{"key":"9686_CR33","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1161\/CIRCRESAHA.112.269894","volume":"111","author":"Q Xiong","year":"2012","unstructured":"Xiong, Q., Ye, L., Zhang, P., et al. (2012). Bioenergetic and functional consequences of cellular therapy: activation of endogenous cardiovascular progenitor cells. Circulation Research, 111, 455\u2013468.","journal-title":"Circulation Research"},{"key":"9686_CR34","doi-asserted-by":"publisher","first-page":"1744","DOI":"10.1093\/eurheartj\/ehv136","volume":"36","author":"AB Mathiasen","year":"2015","unstructured":"Mathiasen, A. B., Qayyum, A. A., J\u00f8rgensen, E., et al. (2015). Bone marrow-derived mesenchymal stromal cell treatment in patients with severe ischaemic heart failure: a randomized placebo-controlled trial (MSC-HF trial). European Heart Journal, 36, 1744\u20131753.","journal-title":"European Heart Journal"}],"updated-by":[{"DOI":"10.1007\/s12265-020-10076-7","type":"expression_of_concern","label":"Expression of concern","source":"retraction-watch","updated":{"date-parts":[[2020,10,19]],"date-time":"2020-10-19T00:00:00Z","timestamp":1603065600000},"record-id":"24486"},{"DOI":"10.1007\/s12265-020-10076-7","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2020,10,19]],"date-time":"2020-10-19T00:00:00Z","timestamp":1603065600000}}],"container-title":["Journal of Cardiovascular Translational Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12265-016-9686-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12265-016-9686-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12265-016-9686-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12265-016-9686-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,22]],"date-time":"2021-06-22T16:49:36Z","timestamp":1624380576000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12265-016-9686-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4,1]]},"references-count":34,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,6]]}},"alternative-id":["9686"],"URL":"https:\/\/doi.org\/10.1007\/s12265-016-9686-0","relation":{"correction":[{"id-type":"doi","id":"10.1007\/s12265-020-10076-7","asserted-by":"object"}]},"ISSN":["1937-5387","1937-5395"],"issn-type":[{"value":"1937-5387","type":"print"},{"value":"1937-5395","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,4,1]]},"assertion":[{"value":"24 October 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 February 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2020","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Clarification","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Editor's Note: The Editor-in-Chief is currently investigating this article (Anastasiadis et al. 2016) as concerns have been raised about the ethics and regulatory approvals related to the cells used in the research. Further editorial action will be taken as appropriate once the investigation into the concerns is complete and all parties have been given an opportunity to respond in full.","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 October 2020","order":7,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":8,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":9,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s12265-020-10076-7","URL":"https:\/\/doi.org\/10.1007\/s12265-020-10076-7","order":10,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"This research received no specific grant from any funding agency in the public, commercial or not-for-profit sectors.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Sources of Funding"}},{"value":"AR, MJE, and SS hold shares in Cell Therapy Limited.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed Consent"}}]}}